Xenetic Biosciences, Inc. is a biopharmaceutical company engaged in the advancement of cell-based therapeutics to target the B-cell receptor on the surface of an individual patient’s malignant tumor cells. Its product pipeline includes XCart Platform and Polyxen. The company was founded on August 9, 2011 and is headquartered in Framingham, MA.
Market Cap
$6.01M
P/E Ratio
-1.47
1Y Stock Return
21.36%
1Y Revenue Growth
7.15%
Dividend Yield
0.00%
Price to Book
0.9
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.
Current Value
$3.811 Year Return
Current Value
$3.811 Year Return
Yahoo
Xenetic Biosciences ( NASDAQ:XBIO ) Third Quarter 2024 Results Key Financial Results Revenue: US$614.2k (flat on 3Q...
Yahoo
Establishing growing body of preclinical data evaluating the DNase-based oncology platform across a number of high-value oncology indications Ongoing progress towards first in human clinical study for locally advanced or metastatic solid tumors Strategic ...
Yahoo
FRAMINGHAM, Mass. AP) — Xenetic Biosciences, Inc. XBIO) on Tuesday reported a loss of $437,000 in its third quarter.
Yahoo
Data presented at Society for Immunotherapy of Cancer (SITC) 2024 Systemic DNase I combined with ?-CTLA-4 antibody demonstrated to promote antitumor immunity and generate immunological memory against microsatellite stable, mismatch repair proficient ...
Yahoo
Company is advancing DNase-based oncology program towards clinical proof-of-concept studies in multiple indications FRAMINGHAM, MA / ACCESSWIRE / November 7, 2024 /Xenetic Biosciences, Inc. (NASDAQ:XBIO) ("Xenetic" or the "Company"), a biopharmaceutical ...
Yahoo
FRAMINGHAM, MA / ACCESSWIRE / October 22, 2024 /Xenetic Biosciences, Inc. (NASDAQ:XBIO) ("Xenetic" or the "Company"), a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing hard to treat oncology indications, ...
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
SUZ | -<0.01% | $13.00B | -2.96% | 2.27% |
LII | -0.01% | $22.21B | +51.90% | 0.72% |
VSTO | 0.01% | $2.58B | +71.61% | 0.00% |
UFI | -0.01% | $102.66M | -11.22% | 0.00% |
CASH | 0.01% | $1.97B | +58.93% | 0.25% |
LKQ | -0.01% | $9.77B | -17.44% | 3.20% |
PFGC | -0.02% | $12.91B | +33.83% | 0.00% |
CMI | -0.02% | $49.64B | +61.69% | 1.90% |
NBR | -0.02% | $694.91M | -21.77% | 0.00% |
NEU | -0.03% | $5.13B | +3.54% | 1.82% |
NXDT | 0.03% | $218.01M | -37.42% | 11.58% |
MPWR | -0.03% | $28.58B | +8.88% | 0.82% |
TDY | -0.03% | $21.66B | +18.31% | 0.00% |
DRS | 0.03% | $9.28B | +88.06% | 0.00% |
VECO | -0.03% | $1.48B | -9.94% | 0.00% |
VSTA | -0.04% | $204.94M | -39.33% | 0.00% |
PGNY | -0.04% | $1.16B | -58.40% | 0.00% |
WSBC | -0.04% | $2.36B | +31.91% | 4.10% |
ENIC | -0.05% | $3.87B | -12.77% | 0.00% |
EGP | -0.05% | $8.62B | +2.17% | 3.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
NEP | 26.33% | $1.48B | -32.95% | 22.91% |
INFA | 25.44% | $7.86B | +5.06% | 0.00% |
LGTY | 24.10% | $392.42M | +14.73% | 4.98% |
NVRI | 23.96% | $552.13M | +20.03% | 0.00% |
BTG | 23.88% | $3.67B | -6.35% | 5.72% |
CDE | 23.33% | $2.66B | +143.96% | 0.00% |
KHC | 23.20% | $36.98B | -10.45% | 5.23% |
AU | 23.15% | $10.58B | +41.93% | 0.90% |
BLDP | 23.14% | $398.23M | -61.89% | 0.00% |
DOC | 22.95% | $14.97B | +30.73% | 5.67% |
UPST | 22.73% | $6.49B | +199.03% | 0.00% |
FSP | 22.49% | $191.60M | -20.60% | 2.17% |
SKLZ | 22.12% | $93.29M | -16.05% | 0.00% |
CLAR | 21.91% | $163.42M | -17.76% | 2.35% |
OPEN | 21.91% | $1.14B | -31.62% | 0.00% |
TGLS | 21.75% | $3.54B | +120.49% | 0.56% |
SIL | 21.73% | $1.55B | +88.25% | 0.00% |
PTON | 21.65% | $3.03B | +49.53% | 0.00% |
FATE | 21.59% | $248.29M | -11.02% | 0.00% |
LCID | 21.57% | $6.32B | -50.24% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
VNOM | -17.62% | $5.48B | +79.62% | 3.35% |
K | -16.74% | $27.77B | +52.50% | 2.79% |
UTZ | -14.86% | $1.37B | +26.87% | 1.41% |
DHT | -14.68% | $1.72B | +5.04% | 9.18% |
PULM | -14.16% | $19.83M | +202.98% | 0.00% |
ASIX | -13.54% | $777.60M | +11.37% | 2.18% |
SCKT | -13.43% | $10.88M | +15.32% | 0.00% |
CRTO | -13.21% | $2.10B | +58.23% | 0.00% |
TRUP | -13.06% | $2.24B | +97.76% | 0.00% |
CME | -12.88% | $82.76B | +9.21% | 1.98% |
CMG | -12.84% | $80.02B | +33.62% | 0.00% |
LQDA | -12.80% | $859.91M | +53.94% | 0.00% |
DVA | -12.67% | $12.87B | +60.92% | 0.00% |
KEX | -12.34% | $7.36B | +65.91% | 0.00% |
EEX | -12.33% | $964.17M | -8.83% | 0.63% |
NTIC | -12.26% | $132.27M | +24.98% | 2.02% |
BJ | -12.09% | $11.45B | +32.57% | 0.00% |
YOU | -12.02% | $2.50B | +34.63% | 1.10% |
EOG | -11.99% | $76.03B | +10.19% | 2.70% |
MMSI | -11.89% | $6.10B | +45.96% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
PINK | 21.29% | $161.15M | 0.5% |
FUTY | 18.68% | $1.73B | 0.084% |
EFAA | 18.47% | $117.38M | 0% |
IBDP | 17.98% | $2.11B | 0.1% |
XLU | 17.95% | $16.89B | 0.09% |
IDU | 17.94% | $1.43B | 0.39% |
IGF | 17.83% | $4.51B | 0.42% |
VPU | 17.83% | $6.66B | 0.1% |
PREF | 17.76% | $999.92M | 0.55% |
VWOB | 17.68% | $5.40B | 0.2% |
JPMB | 17.43% | $585.28M | 0.39% |
UPAR | 17.37% | $70.24M | 0.65% |
FXU | 17.34% | $341.08M | 0.64% |
IZRL | 17.24% | $102.75M | 0.49% |
KNG | 17.24% | $3.53B | 0.75% |
FLDR | 17.16% | $595.01M | 0.15% |
VRP | 17.16% | $1.83B | 0.5% |
IFRA | 17.14% | $3.24B | 0.3% |
HYSA | 17.04% | $28.65M | 0.55% |
PFFD | 16.79% | $2.48B | 0.23% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BSCO | -0.06% | $2.35B | 0.1% |
DBA | 0.09% | $755.88M | 0.93% |
URA | 0.11% | $3.55B | 0.69% |
BTF | 0.21% | $51.69M | 1.24% |
CHIQ | -0.22% | $229.05M | 0.65% |
CRPT | -0.22% | $94.50M | 0.85% |
UNG | 0.26% | $908.80M | 1.06% |
KCCA | 0.40% | $220.51M | 0.87% |
CXSE | -0.42% | $406.30M | 0.32% |
FTLS | 0.44% | $1.62B | 1.46% |
SGOV | 0.53% | $27.53B | 0.09% |
CPER | -0.57% | $159.52M | 0.97% |
DBMF | -0.61% | $1.02B | 0.85% |
FLBL | 0.63% | $645.58M | 0.45% |
EWH | 0.67% | $641.56M | 0.5% |
BITQ | 0.78% | $189.55M | 0.85% |
BLCN | 0.93% | $70.20M | 0.68% |
DBB | -0.97% | $126.37M | 0.77% |
SHLD | 1.05% | $743.22M | 0.5% |
FFOG | 1.05% | $118.40M | 0.55% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
GBIL | -16.07% | $5.60B | 0.12% |
KRBN | -9.67% | $242.47M | 0.85% |
BILZ | -9.46% | $563.02M | 0.14% |
BTAL | -9.07% | $388.04M | 1.43% |
USDU | -8.29% | $201.97M | 0.5% |
FLMI | -8.12% | $356.19M | 0.3% |
VIXY | -8.02% | $195.31M | 0.85% |
FTXN | -7.84% | $179.41M | 0.6% |
CORN | -7.71% | $61.12M | 0.2% |
IEO | -7.40% | $658.25M | 0.4% |
XLE | -7.37% | $37.90B | 0.09% |
HDRO | -7.06% | $164.26M | 0.3% |
DRLL | -6.83% | $336.91M | 0.41% |
CONY | -6.71% | $1.07B | 1.01% |
IYE | -6.67% | $1.35B | 0.39% |
VDE | -6.66% | $8.33B | 0.1% |
PHDG | -6.48% | $113.97M | 0.39% |
EQLS | -6.48% | $76.08M | 1% |
CTA | -6.39% | $350.27M | 0.78% |
JBBB | -6.25% | $1.26B | 0.49% |